Published in Acta Pharmacol Toxicol (Copenh) on October 01, 1978
Exposure-response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tablets. Br J Clin Pharmacol (2007) 0.81
A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients. Br J Clin Pharmacol (1990) 0.75
Acute physiology and chronic health evaluation (APACHE II) and Glasgow coma scores as predictors of outcome from intensive care after cardiac arrest. Crit Care Med (1991) 2.35
Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent. Ann Clin Res (1969) 1.71
Reduction of pain at venous cannulation in children with a eutectic mixture of lidocaine and prilocaine (EMLA cream): comparison with placebo cream and no local premedication. Acta Anaesthesiol Scand (1987) 1.46
Impairing effect of food on ketoconazole absorption. Antimicrob Agents Chemother (1982) 1.32
Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta Anaesthesiol Scand (1993) 1.29
Executive functions and speed of mental processing in elderly patients with frontal or nonfrontal ischemic stroke. Eur J Neurol (1999) 1.27
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol (1998) 1.25
White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry (2005) 1.24
Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route. Antimicrob Agents Chemother (1983) 1.24
Pharmacokinetic studies on atropine with special reference to age. Acta Anaesthesiol Scand (1982) 1.23
Poststroke depression and lesion location revisited. J Neuropsychiatry Clin Neurosci (2004) 1.21
Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry (2006) 1.16
How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol (2000) 1.09
Growth hormone and cortisol secretion after oral and intravenous administration of methyldopa. Acta Pharmacol Toxicol (Copenh) (1975) 1.08
Fibrinolytic treatment in acute myocardial infarction. Acta Med Scand (1972) 1.06
Pharmacokinetics of Carbamazepine in man: a review. Ther Drug Monit (1979) 1.03
Clinical pharmacokinetics of digoxin. Clin Pharmacokinet (1977) 1.02
Carbamazepine and its 10,11-epoxide in children and adults with epilepsy. Eur J Clin Pharmacol (1977) 1.02
Effect of food on the bioavailability of labetalol. Br J Clin Pharmacol (1980) 1.00
The concentrations of diazepam and its metabolites in the plasma after an acute and chronic administration. Psychopharmacologia (1974) 1.00
Magnetic resonance imaging correlates of depression after ischemic stroke. Arch Gen Psychiatry (2001) 0.99
MRI correlates of executive dysfunction in patients with ischaemic stroke. Eur J Neurol (2003) 0.97
The pharmacokinetics of dihydroergotamine in the beagle. Int J Clin Pharmacol Biopharm (1978) 0.97
Letter: Carbamazepine and mother's milk. Lancet (1975) 0.96
Intramuscular absorption of dihydroergotamine in man. Int J Clin Pharmacol Biopharm (1978) 0.95
Human pharmacokinetics of nitrazepam: effect of age and diseases. Eur J Clin Pharmacol (1979) 0.95
Dihydroergotamine: pharmacokinetics and usefulness in spinal anaesthesia. Acta Anaesthesiol Scand (1978) 0.94
Propofol as an induction agent in children: pain on injection and pharmacokinetics. Acta Anaesthesiol Scand (1989) 0.93
Prophylactic fluoride treatment and aged bones. Br Med J (1975) 0.90
Effect of age on the pharmacokinetics of diazepam given in conjunction with spinal anesthesia. Anesthesiology (1979) 0.90
Absorption of ocular timolol: drug concentrations and beta-receptor binding activity in the aqueous humour of the treated and contralateral eye. Acta Ophthalmol (Copenh) (1993) 0.90
The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa. Acta Neurol Scand (1985) 0.90
MRI correlates of dementia after first clinical ischemic stroke. J Neurol Sci (2000) 0.88
Content of free and conjugated 17-hydroxycorticosteroids in plasma of diabetic patients with renal or vascular complications. Ann Med Intern Fenn (1965) 0.88
Hippocampal and temporal lobe atrophy and age-related decline in memory. Acta Neurol Scand (2000) 0.88
Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. Acta Pharmacol Toxicol (Copenh) (1977) 0.88
Impairment of captopril bioavailability by concomitant food and antacid intake. Int J Clin Pharmacol Ther Toxicol (1984) 0.88
Elimination of digoxin during maintenance haemodialysis. Ann Clin Res (1974) 0.85
Medial temporal lobe atrophy and memory deficits in elderly stroke patients. Eur J Neurol (2004) 0.85
Serum digoxin in adults and children. Int J Clin Pharmacol (1973) 0.85
Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin. Int J Clin Pharmacol Ther Toxicol (1985) 0.85
Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort. J Neurol Neurosurg Psychiatry (1999) 0.85
Vasomotor rhinitis and the systemic absorption of ipratropium bromide. Rhinology (1990) 0.84
Effect of tuberculostatic agents on the response of serum growth hormone and immunoreactive insulin to intravenous tolbutamide, and on the half-life of tolbutamide. Int J Clin Pharmacol Biopharm (1976) 0.84
Midazolam as an induction agent in children: a pharmacokinetic and clinical study. Anesth Analg (1987) 0.84
Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke. Stroke (2003) 0.84
The protein binding of diazepam and N-demethyldiazepam in patients with poor renal function. Clin Nephrol (1976) 0.83
Foreign body in the airways of children. Int J Pediatr Otorhinolaryngol (1983) 0.83
Subglottic stenosis in neonates and children. Clinical findings and therapy. Acta Paediatr Scand (1990) 0.83
Single- and multiple-dose pharmacokinetics of pipemidic acid in normal human volunteers. Antimicrob Agents Chemother (1984) 0.83
Systemic absorption of ophthalmic cyclopentolate. Am J Ophthalmol (1989) 0.82
The monitoring of serum chloramphenicol levels in children with severe infections. J Antimicrob Chemother (1985) 0.82
Pharmacokinetics of labetalol in healthy volunteers. Int J Clin Pharmacol Ther Toxicol (1981) 0.82
Antimuscarinic side-effects of disopyramide. Lancet (1983) 0.82
Intramuscular atropine in healthy volunteers: a pharmacokinetic and pharmacodynamic study. Int J Clin Pharmacol Ther Toxicol (1990) 0.82
Human and animal studies on the interactions between glyphylline and isoprenaline. J Asthma Res (1972) 0.82
Midazolam versus atropine plus pethidine as premedication in children. Anaesthesia (1984) 0.82
Tracheobronchial foreign bodies. A persistent problem in pediatric patients. Am J Dis Child (1989) 0.82
Plasma and aqueous humour concentrations and systemic effects of topical betaxolol and timolol in man. Acta Ophthalmol (Copenh) (1993) 0.81
Pharmacokinetics of glycopyrrolate in children. J Clin Anesth (1994) 0.81
The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non-pregnant women. Br J Clin Pharmacol (1992) 0.81
Pharmacokinetics of pipemidic acid in healthy middle-aged volunteers and elderly patients with renal insufficiency. Xenobiotica (1984) 0.81
The effects of beta-adrenoceptor antagonists and levomepromazine on the metabolic ratio of debrisoquine. Br J Clin Pharmacol (1990) 0.81
Placental transfer and pharmacokinetics of atropine after a single maternal intravenous and intramuscular administration. Acta Anaesthesiol Scand (1981) 0.80
Prostaglandin F2 alpha binding to bovine ocular and synthetic melanins in vitro. Pharmacol Toxicol (1989) 0.80
Anticholinergic drugs: effects on oxygen consumption and energy expenditure. Anesth Analg (1994) 0.80
The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans. Int J Clin Pharmacol Ther Toxicol (1982) 0.80
Influence of various diets on the bioavailability of isoniazid. J Antimicrob Chemother (1982) 0.80
Comparison of pharmacokinetic and pharmacodynamic parameters following oral or intramuscular atropine in children. Atropine overdose in two small children. Acta Anaesthesiol Scand (1985) 0.80
Systemic absorption and anticholinergic activity of topically applied tropicamide. J Ocul Pharmacol (1994) 0.80
The pharmacokinetics of carbamazepine in plasma and saliva of man. Acta Pharmacol Toxicol (Copenh) (1977) 0.80
Comparison between propofol and thiopentone for induction of anaesthesia in children. Anaesthesia (1988) 0.80
Effects of glycopyrrolate and atropine on heart rate variability. Acta Anaesthesiol Scand (1991) 0.80
Effect of age and cardiopulmonary bypass on the pharmacokinetics of lorazepam. Acta Pharmacol Toxicol (Copenh) (1982) 0.79
Pharmacological effect of propranolol after a single oral dose. Acta Pharmacol Toxicol (Copenh) (1976) 0.79
Vestibular dysfunction in adult patients with osteogenesis imperfecta. Am J Med Genet A (2003) 0.78
Use of atropine in connection with oral midazolam premedication. Int J Clin Pharmacol Ther Toxicol (1984) 0.78
Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio. Br J Clin Pharmacol (1988) 0.78
Bioavailability of rectal aspirin in neurosurgical patients. Acta Anaesthesiol Scand (1981) 0.78
Hepatotoxicity of paracetamol in combination with interferon and vinblastine. Lancet (1989) 0.78
Beta 1- and beta 2-antagonist activity of topically applied betaxolol and timolol in the systemic circulation. Acta Ophthalmol (Copenh) (1993) 0.78
Concentrations and antagonist activity of topically applied betaxolol in aqueous humour. Acta Ophthalmol (Copenh) (1993) 0.78
Pediatric bronchoscopy. A report of methodology and results. Clin Pediatr (Phila) (1989) 0.77
Plasma and tissue concentrations of methylergometrine (methylergonovine) in the rabbit. Acta Pharmacol Toxicol (Copenh) (1980) 0.77
Kinetics of propiverine as assessed by radioreceptor assay in poor and extensive metabolizers of debrisoquine. Eur J Drug Metab Pharmacokinet (1994) 0.77
Oxyphenbutazone and indomethacin treatment following surgery for varicose veins. Curr Ther Res Clin Exp (1976) 0.77
Current practice regarding invasive monitoring in intensive care units in Finland. A nationwide study of the uses of arterial, pulmonary artery and central venous catheters and their effect on outcome. The Finnish Intensive Care Study Group. Intensive Care Med (1991) 0.77
Beta-blocking effects of timolol at low plasma concentrations. Clin Pharmacol Ther (1991) 0.77
[Mortality from European adder bites?]. Duodecim (1987) 0.77
Pharmacokinetics of graded oral doses of sulindac in man. Arzneimittelforschung (1984) 0.77
Pharmacokinetics of dihydroergotamine in healthy volunteers and in neurological patients after a single intravenous injection. Int J Clin Pharmacol Ther Toxicol (1981) 0.76
Bioavailability and clinical effects of three brands of clonidine: the relationship between plasma level and effect. Int J Clin Pharmacol Ther Toxicol (1982) 0.76
Dihydralazine therapy and acetylator phenotype. Int J Clin Pharmacol Biopharm (1979) 0.76
Single dose pharmacokinetics of doxepin in healthy volunteers. Acta Pharmacol Toxicol (Copenh) (1980) 0.76
Serum levels and renal excretion of digoxin during maintenance therapy in children. Acta Paediatr Scand (1974) 0.76
The effect of metoclopramide and propantheline on the gastrointestinal absorption of cimetidine. Br J Clin Pharmacol (1981) 0.76